ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 485

Bone Loss in Different Sites over Time in Patients with Rheumatoid Arthritis

Rachel Tribbick1, Marco Massarotti2, Jemma G Kerns3, Frank Dondelinger1 and Marwan Bukhari4, 1CHICAS, Lancaster University, Lancaster, United Kingdom, 2Rheumatology, Royal Lancaster Infirmary, University Hospital of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom, 3Medical School, Lancaster University, Lancaster, United Kingdom, 4Royal Lancaster Infirmary, Lancaster, United Kingdom

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Bone density and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I: Comorbidities

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is described as an independent risk factor for osteoporosis and is included in models, including the FRAX™ tool which uses bone mineral density (BMD) as well as demographics to predict fracture risk. Most dual X-ray absorptiometry (DEXA) scans only measure the non-dominant hip. Published data are from existing datasets that are X-sectional and the influence of factors on progression of BMD loss in different sites has not be studied. We aimed to test the hypothesis that bone loss over time is more pronounced in patients with RA, compared to those without.

Methods: We used data from patients referred for DEXA in the North West of England from June 2004 and October 2016. Patients have their FRAX™ risk factors assessed and their BMD measured in both femoral necks, shaft, trochanter and Wards triangle in addition to L1-L4 in the lumbar spine (LS). Patients attending for multiple scans in this period without a diagnosis of RA were used as a comparator group. A longitudinal mixed-effects model was fitted, with BMD at each site as the exposure, adjusting for all risk factors for OP in addition to fitting interaction terms for bisphosphonate use in addition to calcium/vitamin D use.

Results:

6941 patients were included, 6169 (88.9%) were females. Of whom 1270 (20.5%) were menopausal. Mean age was 63 years (SD 11.3 years) and 749 patients with RA (named the RA group) had multiple scans and were compared to the 6192 without an RA diagnosis. There are an average of 2.35 scans per patient (SD 0.64 scans),an average of 4.26 years apart (SD 1.88 years). Patients in the RA group had significantly higher average BMD in the lumber spine than those in the non-RA group. There was no significant difference in the bone mineral density of the femur between the RA and non-RA groups. Conversely patients in the RA group lost BMD faster in the femur than the non-RA group, but BMD loss in the lumbar spine was not significantly different between groups.

Figure 1. Showing the results of the longitudinal analysis for average BMD (top) and bone loss over time (bottom)

Conclusion: The average BMD in the lumbar spine is higher in the RA group than in the non-RA group, but bone loss appears to be increased in the femur at all sites of measurement. The most likely explanation is increasing OA in the lumbar spine causing slower loss of BMD. This is clinically significant because bone loss in the hip is used as a predictor for fracture and the rapid bone loss seen would necessitate reducing the interval between scans in this group of patients. Limitations of the study include lack of information about length of disease and specific treatments history for the RA patients.


Disclosure: R. Tribbick, None; M. Massarotti, None; J. G. Kerns, None; F. Dondelinger, None; M. Bukhari, None.

To cite this abstract in AMA style:

Tribbick R, Massarotti M, Kerns JG, Dondelinger F, Bukhari M. Bone Loss in Different Sites over Time in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/bone-loss-in-different-sites-over-time-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bone-loss-in-different-sites-over-time-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology